超声造影对肝细胞癌与肝转移癌的鉴别诊断价值分析

doi:10.3969/j.issn.1672-5069.2020.01.026

Abstract

Abstract: Objective The purpose of this study was to investigate the application of contrast-enhanced ultrasound (CEUS) in differential diagnosis of hepatocellular carcinoma (HCC) and liver metastases (LM). Methods 77 patients with HCC (79 foci) and 40 patients with LM (41 foci) were recruited in our hospital, and routine sonography and CEUS were conducted. Results The enhancement type I, type II and type III in patients with HCC were 2.5%, 26.6% and 70.9%, significantly different as compared to 36.6%, 9.8% and 53.7%, respectively, in patients with LM (P＜0.05); the peak time of enhancement and the time of washing out in HCC foci were (29.16±7.87)s and (51.89±22.80)s, significantly different as compared to 【(25.98±5.30) and (37.49±10.68)s, respectively, P＜0.05 】 in LM foci. Conclusion The performance of CEUS in differentiating HCC and LM foci is efficacious, which might be helpful in clinical practice.

Key words: Hepatocellular carcinoma, Liver metastasis, Contrast enhanced ultrasound, Diagnosis

Liu Xiao, He Nian’an, Ye Xianjun, et al. Application of contrast-enhanced ultrasound in differential diagnosis of hepatocellular carcinoma and liver metastases[J]. Journal of Practical Hepatology, 2020, 23(1): 94-97.

References

[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics,2012. CA Cancer J Clin,2015,65(2):87-108.
[2] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China,2015. CA:A Cancer J Clin,2016,66(2):115-132.
[3] Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int, 2017, 11(4): 317370.
[4] Quaia E, Bertolotto M, Forgaces B, et al. Detection of liver metastases by pulse inversion harmonic imaging during Levovist late phase: comparison with conventional ultrasound and helical CT in 160 patients. Eur Radiol, 2003, 13(3):475-483.
[5] Jang HJ, Kim T, Burns PN, et al. CEUS:an essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma. Eur J Radiol,2015,84(9):1623-1635.
[6] 乔志忠. 超声造影定量分析鉴别肝脏局灶性结节性增生与原发性肝癌初步探讨.实用肝脏病杂志,2019,22(3):421-424.
[7] 尹珊珊,陈敏华,严昆,等. 超声造影对肝转移癌的诊断价值.中华超声影像学杂志,2005,14(5):354-358.
[8] 李颖嘉,文戈,吴凤林. 超声造影定量分析对乳腺良恶性肿瘤区域血流动力学灌注特征的研究.生物医学工程与临床,2009,13(5):431-435.
[9] Albrecht T, Holumnn J, Oldenburg A, et al. Detection and characterisation of liver metastases. Eur Radiol,2004,14(8):25-33.
[10] Ogawa S, Kumada T, Toyoda H. Evaluation of pathological features of hepatocellular carcinoma by contrast-enhanced ultrasonography: comparison with pathology on resected specimen. Eur J Radiol,2006,59(1):74-81.
[11] Wang YC, Chou CT, Lin CP, et al. The value of Gd-EOB-DTPA enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images. PLoS One, 2017, 12(3):e0174594.
[12] Ling W, Wang M, Ma X, et al. The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2 cm). J Cancer, 2018, 9(16): 2946-2952.
[13] He Y, Liu F, Mou S, et al. Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast enhanced ultrasound and pathology. Oncol Lett,2018,15(3): 3746-3752.
[14] Facciorusso A, Licinio R, Muscatiello N, et al. Transarterial chemoembolization: evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol, 2015, 7(16): 2009-2019.
[15] Ikemoto T, Shimada M, Yamada S. Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation. Hepatol Res,2017,47(1):23-30.
[16] Kim TK,Jang HJ. Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis. World J Gastroenterol,2014,20(13):3590-3596.
[17] 郭振宁. 超声造影诊断微小原发性肝癌患者临床价值研究.实用肝脏病杂志,2018,21(5):741-744.
[18] Yang D, Li R, Zhang XH, et al. Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound: influence of the cellular differentiation, the tumor size and the underlying hepatic condition. Sci Rep,2018,8(1) :4713.
[19] Kazuhiro K, Yoichiro K, Masahiko H, et al. Ring enhancement on T1-weighted GRE images after ferucarbotran administration for hepatic metastasis: comparison with pathological findings: case report. Radiat Med,2005,23(1): 75-79.
[20] 韩峰,邹如海,裴小青,等. 超声造影定量分析鉴别富血供转移性肝癌与肝细胞癌.中国医学影像技术,2011,27(10):2079-2082.
[21] Kong ET, JI ZB, Wang WP, et al. Evaluation of liver metastases using contrast-enhanced ultrasound:enhancement patterns and influencing factors. Gut Liver,2016,10(2):283-287.

Application of contrast-enhanced ultrasound in differential diagnosis of hepatocellular carcinoma and liver metastases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xu Xiaoyuan. Highlights of newly released guideline for diagnosis and treatment of liver cirrhosis [J]. Journal of Practical Hepatology, 2020, 23(1): 4-6.
[2]	Yang Kezhi, Lu Wei, Huang Dan, et al. Diagnostic value of gamma-glutamyl transpeptidase to cholinesterase ratio in predicting hepatic fibrosis in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2020, 23(1): 14-17.
[3]	Ye Xirong, Lyu Zhihong, Jiang Feng, et al. Clinical value of transient elastography and two-dimensional shear wave elastography in the diagnosis of liver fibrosis in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2020, 23(1): 18-21.
[4]	Chen Lili, Fu Maoxiong, Meng Xubiao, et al. Clinical value of fasting C-peptide in assessing the progression of liver fibrosis in patients with NAFLD and T2DM [J]. Journal of Practical Hepatology, 2020, 23(1): 38-41.
[5]	Liu Jian, Zhu Fengfa, Tang Juan. Ultrasonographic and biochemical features of patients with non-alcoholic heterogeneous fatty liver [J]. Journal of Practical Hepatology, 2020, 23(1): 42-45.
[6]	Wang Jingjing, Li Chuntao, Zhou Weizhen. Urineretinol binding protein levels in patients with hepatitis B-induced decompensated liver cirrhosis as the index for acute kidney injury [J]. Journal of Practical Hepatology, 2020, 23(1): 74-77.
[7]	Shi Yingying, Wang Yuanxi. Application of liver imaging report and data management system in diagnosis of hepatocellular carcinoma in CT and MR examinations [J]. Journal of Practical Hepatology, 2020, 23(1): 98-101.
[8]	Gao Li, Gao Yi, Yin Qiuping. Clinical value of CT perfusion imaging combined with color Doppler sonography in the diagnosis of hepatic nodular lesions [J]. Journal of Practical Hepatology, 2020, 23(1): 106-109.
[9]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Imaging feature of patients with microvesicular polycystic liver [J]. Journal of Practical Hepatology, 2020, 23(1): 114-117.
[10]	Wang Chun, Chen Dongfeng. Fitz-Hugh-Curtis syndrome: What we know about? [J]. Journal of Practical Hepatology, 2020, 23(1): 149-152.
[11]	Chen Huiting, Zhou Yongjian. Diagnosis and management of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2020, 23(1): 153-155.
[12]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[13]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[14]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[15]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.